Hogan Lovells Supports Riaan Research Initiative in Securing FDA Clearance of IND for Experimental Gene Therapy to Treat Cockayne Syndrome
June 12, 2026
June 12, 2026
LONDON, England, June 12 -- Hogan Lovells, a law firm, issued the following news release:
* * *
Hogan Lovells supports Riaan Research Initiative in securing FDA clearance of IND for experimental gene therapy to treat Cockayne syndrome
New York - Global law firm Hogan Lovells provided pro bono legal counsel to the Riaan Research Initiative (RRI), a rare disease patient advocacy organization based in New York City, in securing U.S. Food and Drug Administratio . . .
* * *
Hogan Lovells supports Riaan Research Initiative in securing FDA clearance of IND for experimental gene therapy to treat Cockayne syndrome
New York - Global law firm Hogan Lovells provided pro bono legal counsel to the Riaan Research Initiative (RRI), a rare disease patient advocacy organization based in New York City, in securing U.S. Food and Drug Administratio . . .